Letter To The Editor

PEDIATRICS ◽  
1978 ◽  
Vol 62 (3) ◽  
pp. 438-439
Author(s):  
Myron E. Wegman

Dr. Talbot is quite right that social and demographic factors have considerable influence on the neonatal death rate, as for almost any specific rate. As I stated, improved neonatal care seemed to me a factor because the neonatal rate had dropped much more rapidly than the postneonatal rate. I may well have given too much weight to this observation. On the other hand, I fear that, while Dr. Talbot's proposed case fatality rate could be useful and worth doing to analyze a particular hospital's experience, it would lead to more uncertainty than precision about the community.

2021 ◽  
Author(s):  
Karla Flores Sacoto ◽  
Galo Sánchez Del Hierro ◽  
Xavier Jarrín Estupiñan ◽  
Felipe Moreno-Piedrahita Hernandez

Abstract Background COVID-19 has caused deaths worldwide affecting the most vulnerable population with different case fatality rates. Socioeconomic conditions have demonstrated a role regarding the spread of infections and mortality. Socioeconomic characteristics of Ecuador related to poverty, ethnicity and demographic characteristics increase the impact of COVID-19 in certain populations. Methods Objective To analyze the influence of demographic factors on the COVID-19 case fatality rate (CFR) in Ecuador. Design: cross sectional study. Setting 24 provinces in Ecuador-221 cantons. Population: data including 233.277 confirmed COVID-19 cases of Ecuador. Primary and secondary outcome measures COVID-19 CFR and crude cause-specific death rate weight calculated using province-country level data from health ministry of Ecuador in data website. Results Ecuadors CFR is 4,03%, analyzed by cantons the CFR increases to a median of 5,75%, with cantons like Playas with a CFR of 32,39%. The morbidity rate has a median of 795,31 per 100 000 hab. with the highest rate in Isabela-Galápagos (10185,49), Aguarico-Orellana (9506,75) and Baños-Tungurahua (4156,85). And the crude COVID-19 death rate has a median of 39,73 per 100 000 hab. with the highest rate in Penipe-Chimborazo (201,29), 24 de Mayo-Manabí (143,79) and San Pedro de Huaca-Carchi (134,36). The correlations show relations with sociodemographic factors like poverty, ethnicity and scholarity. Conclusion The CFR is the proxy indicator of COVID-19 impact in Ecuador and the analysis made by location give us new information about the specific impact of this disease.


Author(s):  
Siuli Mukhopadhyay ◽  
Debraj Chakraborty

Background and ObjectivesWhile the number of detected COVID-19 infections are widely available, an understanding of the extent of undetected COVID-19 cases is urgently needed for an effective tackling of the pandemic and as a guide to lifting the lockdown. The aim of this work is to estimate and predict the true number of COVID-19 (detected and undetected) infections in India for short to medium forecast horizons. In particular, using publicly available COVID-19 infection data up to 28th April 2020, we forecast the true number of infections in India till the end of lockdown (3rd May) and five days beyond (8th May).MethodsThe high death rate observed in most COVID-19 hit countries is suspected to be a function of the undetected infections existing in the population. An estimate of the age weighted infection fatality rate (IFR) of the disease of 0.41%, specifically calculated by taking into account the age structure of Indian population, is already available in the literature. In addition, the recorded case fatality rate (CFR= 1%) of Kerala, the first state in India to successfully flatten the curve by consistently reporting single digit new infections from 12-20 April, is used as a second estimate of the IFR. These estimates are used to formulate a relationship between deaths recorded and the true number of infections and recoveries. The estimated undetected and detected cases time series based on these two IFR estimates are then used to fit a discrete time multivariate infection model to predict the total infections at the end of the formal lockdown period.ResultsOver three consecutive fortnight periods during the lockdown, it was noted that the rise in detected infections has decreased by 8.2 times. For an IFR of 0.41%, the rise in undetected infections decreased 2.5 times, while for the higher IFR value of 1%, undetected cases decreased by 2.4 times. The predicted number of total infections in India on 3rd May for both IFRs varied from 2.8 - 6.8 lakhs.Interpretation and ConclusionsThe behaviour of the undetected cases over time effectively illustrates the effects of lockdown and increased testing. From our estimates, it is found that the lockdown has brought down the undetected to detected cases ratio, and has consequently dampened the increase in the number of total cases. However, even though the rate of rise in total infections has fallen, the lifting of the lockdown should be done keeping in mind that 2.3 to 6.4 lakhs undetected cases will already exist in the population by 3rd May.


2020 ◽  
Author(s):  
Octavio Bramajo ◽  
Mauro Infantino ◽  
Rafael Unda ◽  
Walter D Cardona-Maya ◽  
Pablo Richly

AbstractThe search for accurate indicators to compare the pandemic impact between countries is still a challenge. The crude death rate, case fatality rate by country and sex, standardized fatality rate, and standardized death rate were calculated using data from Argentina and Colombia countries. We show that even when frequently used indicator as deaths per million are quite similar, 512 deaths per million in Argentina and 522 deaths per million in Colombia, a significant heterogeneity can be found when the mortality data is decomposed by sex or age.


2020 ◽  
Vol 30 (3) ◽  
pp. 344-354
Author(s):  
Henrique de Moraes Bernal ◽  
Carlos Eduardo Siqueira ◽  
Fernando Adami ◽  
Edige Felipe de Sousa Santos

Introduction: CoV infections can potentially cause from a simple cold to a severe respiratory syndrome, such as the Severe Acute Respiratory Syndrome and the Middle East Respiratory Syndrome (MERS-CoV). The COVID-19 created a new reality for global healthcare models. Objetive: To evaluate trends in case fatality rates of COVID-19 in the World. Methods: We conducted a population based time-series study using public and official data of cases and deaths from COVID-19 in Argentina, Australia, Brazil, Chile, China, Colombia, France, Germany, India, Iran, Italy, Japan, Mexico, Morocco, New Zealand, Nigeria, Peru, Saudi Arabia, South Africa, South Korea, Spain, Switzerland, United Kingdom, United States and Russian, between December, 2019 and August, 2020. Data were based on reports from European Centre for Disease Prevention and Control. COVID-19 was defined by the International Classification of Diseases, 10th revision (U07.1). A Prais-Winsten regression model was performed and the Daily Percentage Change (DPC) calculated determine rates as increasing, decreasing or flat. Results: During the study period, trends in case-fatality rates in the world were flat (DPC = 0.3; CI 95% [-0.2: 0.7]; p = 0.225). In Africa, Morocco had decreasing trends (DPC = -1.1; CI 95% [-1.5: -0.7]; p < 0.001), whereas it were increasing in South Africa (p < 0.05) and flat in Nigeria (p > 0.05). In the Americas, Argentina showed a decreasing trend in case-fatality rates (DPC = -0.6; CI 95% [-1.1: -0.2]; p = 0.005), the U.S. had flat trends (p > 0.05) and all other American countries had increasing trends (p < 0.05). In Asia, Iran had decreasing trends (DPC = -1.5; CI 95% [-2.6 : -0.2]; p = 0.019); China and Saudi Arabia showed increasing trends (p < 0.05), while in India, Japan and South Korea they were flat (p > 0.05). European countries had mostly increasing trends (p < 0.05): Germany, Italy, Spain, the UK and Russia; France and Switzerland had flat trends (p > 0.05). Finally, in Oceania, trends in case-fatality rates were flat in Australia (p > 0.05) and increasing in New Zealand (p < 0.05). Conclusion: Trends in case-fatality rates of COVID-19 in the World were flat between December, 31 and August, 31. Argentina, Iran and Morocco were the only countries with decreasing trends. On the other hand, South Africa, Brazil, Canada, Chile, Colombia, Mexico, Peru, China, Saudi Arabia, Germany, Spain, United Kingdom, Russian and New Zealand had increasing trends in case-fatality rate. All the other countries analyzed had flat trends. Based on case-fatality rate data, our study supports that COVID-19 pandemic is still in progress worldwide.


BMJ Open ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. e043560 ◽  
Author(s):  
Yang Cao ◽  
Ayako Hiyoshi ◽  
Scott Montgomery

ObjectiveTo investigate the influence of demographic and socioeconomic factors on the COVID-19 case-fatality rate (CFR) globally.DesignPublicly available register-based ecological study.SettingTwo hundred and nine countries/territories in the world.ParticipantsAggregated data including 10 445 656 confirmed COVID-19 cases.Primary and secondary outcome measuresCOVID-19 CFR and crude cause-specific death rate were calculated using country-level data from the Our World in Data website.ResultsThe average of country/territory-specific COVID-19 CFR is about 2%–3% worldwide and higher than previously reported at 0.7%–1.3%. A doubling in size of a population is associated with a 0.48% (95% CI 0.25% to 0.70%) increase in COVID-19 CFR, and a doubling in the proportion of female smokers is associated with a 0.55% (95% CI 0.09% to 1.02%) increase in COVID-19 CFR. The open testing policies are associated with a 2.23% (95% CI 0.21% to 4.25%) decrease in CFR. The strictness of anti-COVID-19 measures was not statistically significantly associated with CFR overall, but the higher Stringency Index was associated with higher CFR in higher-income countries with active testing policies (regression coefficient beta=0.14, 95% CI 0.01 to 0.27). Inverse associations were found between cardiovascular disease death rate and diabetes prevalence and CFR.ConclusionThe association between population size and COVID-19 CFR may imply the healthcare strain and lower treatment efficiency in countries with large populations. The observed association between smoking in women and COVID-19 CFR might be due to the finding that the proportion of female smokers reflected broadly the income level of a country. When testing is warranted and healthcare resources are sufficient, strict quarantine and/or lockdown measures might result in excess deaths in underprivileged populations. Spatial dependence and temporal trends in the data should be taken into account in global joint strategy and/or policy making against the COVID-19 pandemic.


2020 ◽  
Author(s):  
Tsair-Wei Chien ◽  
Wei-Chih Kan ◽  
Yu-Tsen Yeh ◽  
Shu-Chun Kuo

BACKGROUND When a new disease starts to spread, one of the commonly asked questions is (1) how deadly it is. World Health Organization (WHO) announced in a press conference on January 29th, 2020 and reported the death rate of COVID-19 was 2% on the case fatality rate(CFR). Whether the claim was underestimated is worthy of clarifications when considering the lag days from symptom onset to death. OBJECTIVE We developed an app for online displaying three types of computations of CFR and verifying the death rate of 2% substantially underestimated. METHODS We downloaded COVID-19 outbreak numbers from January 21 to February 25, 2020, in countries/regions on a daily basis from Github that contains daily information on confirmed cases, deaths, and the recovered in more than 30 Chinese locations and other worldwide countries/regions. Three CFRs on COVID-19 were compared, including (A) deaths/confirmed;(B) deaths/(deaths+recovered); and (C) deaths/(cases x days ago). The coefficients of variance (CV=the ratio of the standard deviation to the mean) were applied to measure the relative variability for each CFR. A dashboard was developed for daily display of the CFR on COVID-19 for each region. RESULTS We observed that the CVs were 0.07, 9.23, and 5.08 and the CFRs were 3.37%, 8.85%, and 3.58% for these three CFR computations, respectively, on Feb. 25, 2020. The death rate of COVID-19(=2%) announced by WHO using the formula of deaths/confirmed was substantially underestimated. A dashboard was created to present the provisional CFRs of COVID-19 on a daily basis. CONCLUSIONS We suggest examining these three CFRs as a reference to the final CFR. An app developed for displaying the provisional CFR with these three CFRs can modify the underestimated CFR reported by WHO and media. CLINICALTRIAL Not available


1944 ◽  
Vol 43 (5) ◽  
pp. 341-348 ◽  
Author(s):  
H. S. Carter

1. A general survey of diphtheria in Glasgow during 1934–42 has been made. Over 11,000 strains ofC. diphtheriaehave been typed and the incidence of the types is recorded.2. The period has been marked by a change in the predominant type of organism fromintermediustogravis, andgravisinfections are now responsible for most of the mortality, though the average case fatality rate due to them is not high.3. Diphtheria on the whole has been mild and complications relatively few, but some shift in the death-rate incidence to the higher age periods with increase in the corresponding case fatality rate has taken place. A small shift in the age incidence of diphtheria is noted.4. Some account of the effect of immunization is given.5. Comment is made upon colony variation among the types ofC. diphtheriae.


2021 ◽  
Vol 6 (2) ◽  
pp. 90-93
Author(s):  
Ramakrishna Rachakonda ◽  
Kiranmavi Abburi ◽  
Sai Ramya Gonuguntla ◽  
Bhavanarayana Jannela ◽  
Chakradhar Bolleddu ◽  
...  

We have studied the pattern of COVID-19 epidemic in Andhra Pradesh and compared with other high burden states in India utilizing Government of India statistics. We have compared the Indian figures with the statistics in other countries. We have analyzed the data published by Ministry of Health and family Welfare Government of India, Government of Andhra Pradesh and WHO statistics as well as worldometer statistics. We have studied the hospital statistics of our tertiary care COVID center and analyzed the results.The statistics revealed highest number of cases are seen in United States of America with case fatality rate of 1.74%.Mexico has highest case fatality rate of 8.5%. Italy has 3.5% and United Kingdom 2.8%.In India Maharashtra has highest number of COVID-19 casualties with case fatality of 2.52%. Indian national average of case fatality is 1.47%. Andhra Pradesh has a case fatality of 0.80%. In Andhra Pradesh the pandemic of COVID-19 peaked in the months of August and September both in terms of number of cases and deaths and then decline started. Hospital based records showed a death rate of 3.92%.


2020 ◽  
Vol 54 (5) ◽  
pp. 467-481 ◽  
Author(s):  
Dan Siskind ◽  
Ashneet Sidhu ◽  
John Cross ◽  
Yee-Tat Chua ◽  
Nicholas Myles ◽  
...  

Background: Clozapine is the most effective medication for treatment refractory schizophrenia, but is associated with cardiac adverse drug reactions. Myocarditis and cardiomyopathy are the most serious cardiac adverse drug reactions although reported rates of these conditions vary in the literature. We systematically reviewed and meta-analysed the event rates, the absolute death rates and case fatality rates of myocarditis and cardiomyopathy associated with clozapine. Methods: PubMed, EMBASE and PsycINFO were searched for studies that reported on the incidence of cardiomyopathy or myocarditis in people exposed to clozapine. Data were meta-analysed using a random effects model, with subgroup analysis on study size, time frame, region, quality, retrospective vs prospective, and diagnostic criteria of myocarditis or cardiomyopathy. Results: 28 studies of 258,961 people exposed to clozapine were included. The event rate of myocarditis was 0.007 (95% confidence interval [CI] = [0.003, 0.016]), absolute death rate was 0.0004 (95% CI = [0.0002, 0.0009]) and case fatality rate was 0.127 (95% CI = [0.034, 0.377]). The cardiomyopathy event rate was 0.006 (95% CI = [0.002, 0.023]), absolute death rate was 0.0003 (95% CI = [0.0001, 0.0012]) and case fatality rate was 0.078 (95% CI = [0.018, 0.285]). Few included studies provided information on criteria for diagnosis of myocarditis and cardiomyopathy. Event rates of cardiomyopathy and myocarditis were higher in Australia. Conclusion: Clarity of diagnostic criteria for myocarditis remains a challenge. Observation bias may, in part, influence higher reported rates in Australia. Monitoring for myocarditis is warranted in the first 4 weeks, and treatment of comorbid metabolic syndrome and diabetes may reduce the risk of cardiomyopathy. The risks of myocarditis and cardiomyopathy are low and should not present a barrier to people with treatment refractory schizophrenia being offered a monitored trial of clozapine.


Sign in / Sign up

Export Citation Format

Share Document